Table A5.
CFS: value at baseline and at each post-baseline visit—PPS (n = 84)—descriptive analysis by subgroup.
| Comfort Shield | Control | ||||
|---|---|---|---|---|---|
| Desert (n = 6) | Europe (n = 38) | Desert (n = 7) | Europe (n = 33) | ||
| value at baseline | n | 6 | 38 | 7 | 33 |
| mean (sd) | 3.79 (0.71) | 4.04 (0.52) | 4.11 (0.61) | 4.30 (0.55) | |
| median (iqr) | 3.62 (3.37, 4.05) | 3.94 (3.59, 4.39) | 3.95 (3.60, 4.56) | 4.41 (3.80, 4.65) | |
| min, max | 3, 5 | 3, 5 | 3, 5 | 3, 5 | |
| missing | 0 | 0 | 0 | 0 | |
| value at week 4 | n | 5 | 36 | 6 | 32 |
| mean (sd) | 3.37 (0.89) | 3.89 (0.82) | 2.22 (1.53) | 3.72 (1.05) | |
| median (iqr) | 3.74 (2.81, 4.09) | 4.00 (3.43, 4.54) | 2.15 (1.41, 3.36) | 3.93 (3.25, 4.48) | |
| min, max | 2, 4 | 1, 5 | 0, 4 | 0, 5 | |
| missing | 1 | 2 | 1 | 1 | |
| value at week 8 | n | 6 | 35 | 6 | 32 |
| mean (sd) | 3.79 (1.30) | 3.94 (0.97) | 2.21 (1.91) | 3.88 (0.83) | |
| median (iqr) | 4.20 (2.60, 4.84) | 4.31 (3.38, 4.68) | 2.56 (0.58, 3.22) | 3.99 (3.37, 4.45) | |
| min, max | 2, 5 | 0, 5 | 0, 5 | 2, 5 | |
| missing | 0 | 3 | 1 | 1 | |